Insider Transactions in Q4 2020 at Acadia Pharmaceuticals Inc (ACAD)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2020
|
Srdjan R. Stankovic President |
SELL
Open market or private sale
|
Direct |
2,728
-14.17%
|
$144,584
$53.5 P/Share
|
|
Nov 19
2020
|
Srdjan R. Stankovic President |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+24.5%
|
-
|
|
Oct 27
2020
|
Austin D. Kim EVP,General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
8,750
-69.44%
|
$393,750
$45.1 P/Share
|
|
Oct 27
2020
|
Austin D. Kim EVP,General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+40.98%
|
$148,750
$17.58 P/Share
|
|
Oct 16
2020
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
2,960
-16.68%
|
$124,320
$42.56 P/Share
|
|
Oct 16
2020
|
Srdjan R. Stankovic President |
SELL
Open market or private sale
|
Direct |
1,297
-9.07%
|
$54,474
$42.56 P/Share
|
|
Oct 16
2020
|
Michael J. Yang EVP and CCO |
SELL
Open market or private sale
|
Direct |
1,247
-16.19%
|
$52,374
$42.56 P/Share
|
|
Oct 15
2020
|
Stephen Davis CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,937
+25.07%
|
-
|
|
Oct 15
2020
|
Srdjan R. Stankovic President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,969
+17.19%
|
-
|
|
Oct 15
2020
|
Michael J. Yang EVP and CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+24.5%
|
-
|